TN2010000450A1 - Fused ring compounds and use thereof - Google Patents
Fused ring compounds and use thereofInfo
- Publication number
- TN2010000450A1 TN2010000450A1 TNP2010000450A TN2010000450A TN2010000450A1 TN 2010000450 A1 TN2010000450 A1 TN 2010000450A1 TN P2010000450 A TNP2010000450 A TN P2010000450A TN 2010000450 A TN2010000450 A TN 2010000450A TN 2010000450 A1 TN2010000450 A1 TN 2010000450A1
- Authority
- TN
- Tunisia
- Prior art keywords
- fused ring
- ring compounds
- present
- glucokinase activator
- agent
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229940124828 glucokinase activator Drugs 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention aims to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2009/057625 WO2009125873A1 (en) | 2008-04-10 | 2009-04-09 | Fused ring compounds and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000450A1 true TN2010000450A1 (en) | 2011-12-29 |
Family
ID=44860625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2010000450A TN2010000450A1 (en) | 2009-04-09 | 2010-09-30 | Fused ring compounds and use thereof |
Country Status (2)
| Country | Link |
|---|---|
| TN (1) | TN2010000450A1 (en) |
| TW (1) | TWI454473B (en) |
-
2009
- 2009-09-24 TW TW098132256A patent/TWI454473B/en not_active IP Right Cessation
-
2010
- 2010-09-30 TN TNP2010000450A patent/TN2010000450A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI454473B (en) | 2014-10-01 |
| TW201036965A (en) | 2010-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA97257C2 (en) | Indole derivatives | |
| MY152475A (en) | Fused ring compounds and use thereof | |
| MX2010009736A (en) | Heterocyclic compound. | |
| PH12013501099A1 (en) | Bicyclic compound | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| MY149648A (en) | Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
| MY154798A (en) | Fused cyclic compounds | |
| MX2011005934A (en) | Organic compounds. | |
| MX2010002419A (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament. | |
| MX2011011854A (en) | Dihydropyrimidinones for use as bace2 inhibitors. | |
| IN2012DN01233A (en) | ||
| MX2011011661A (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750. | |
| MX353500B (en) | Heterocyclic compound. | |
| JO3067B1 (en) | Pyrazolylaminopyridines as inhibitors of fak | |
| MX2010008460A (en) | Thiazole derivative and use thereof as vap-1 inhibitor. | |
| GB0812642D0 (en) | Compounds | |
| PH12012502347A1 (en) | Bicyclic compound derivatives and their use as acc inhibitors | |
| GEP20156315B (en) | Oxazoline and isoxazoline derivatives as crac modulators | |
| MX2010003440A (en) | Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof. | |
| MX2010003442A (en) | Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof. | |
| JO2999B1 (en) | Tricyclic Compound And Pharmaceutical Use Therof | |
| MX2012007253A (en) | Tricyclic derivatives and their pharmaceutical use and compositions. | |
| MX2012004087A (en) | Sulfonamides for the prevention of diabetes. | |
| TN2010000450A1 (en) | Fused ring compounds and use thereof | |
| GEP20146008B (en) | Fluorinated derivatives of 3-hydroxypyridin-4-ones |